Marc Grasso's Insider Trades & SAST Disclosures
Marc Grasso's most recent trade in Alector Inc was a trade of 18,091 Common Stock done at an average price of $1.5 . Disclosure was reported to the exchange on March 3, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Marc Grasso.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Alector Inc | Marc Grasso | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.47 per share. | 03 Mar 2025 | 18,091 | 312,560 (0%) | 0% | 1.5 | 26,547 | Common Stock |
| Alector Inc | Grasso Marc | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 2.52 per share. | 02 Dec 2024 | 16,489 | 330,651 (0%) | 0% | 2.5 | 41,542 | Common Stock |
| Alector Inc | Marc Grasso | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 216,400 | 347,140 (0%) | 0% | 0 | Common Stock | |
| Alector Inc | Marc Grasso | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 4.88 per share. | 03 Sep 2024 | 7,297 | 130,740 (0%) | 0% | 4.9 | 35,620 | Common Stock |
| Alector Inc | Marc Grasso | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 4.80 per share. | 03 Jun 2024 | 6,920 | 138,037 (0%) | 0% | 4.8 | 33,208 | Common Stock |
| Alector Inc | Marc Grasso | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.92 per share. | 04 Mar 2024 | 5,716 | 144,957 (0%) | 0% | 6.9 | 39,562 | Common Stock |
| Alector Inc | Grasso Marc | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 5.56 per share. | 04 Dec 2023 | 4,574 | 150,673 (0%) | 0% | 5.6 | 25,431 | Common Stock |
| Alector Inc | Marc Grasso | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.90 per share. | 02 Jun 2023 | 1,050 | 33,361 (0%) | 0% | 6.9 | 7,249 | Common Stock |
| Alector Inc | Marc Grasso | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 8.32 per share. | 02 Mar 2023 | 1,291 | 34,411 (0%) | 0% | 8.3 | 10,739 | Common Stock |
| Alector Inc | Marc Grasso | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2022 | 35,702 | 35,702 (0%) | 0% | 0 | Common Stock | |
| Alector Inc | Marc Grasso | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2022 | 23,801 | 23,801 | - | - | Employee Stock Option (right to buy) | |
| Alector Inc | Marc Grasso | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 450,000 | 450,000 | - | - | Employee Stock Option (right to buy) | |
| Kura Oncology Inc | Marc Grasso | CFO, CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2022 | 131,000 | 131,000 | - | - | Option to purchase common stock | |
| Kura Oncology Inc | Marc Grasso | CFO, CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2022 | 21,900 | 21,900 (0%) | 0% | 0 | Common Stock | |
| Kura Oncology Inc | Marc Grasso | CFO, CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2021 | 175,000 | 175,000 | - | - | Option to purchase common stock | |
| Kura Oncology Inc | Marc Grasso | CFO, CBO | Sale of securities on an exchange or to another person at price $ 29.00 per share. | 14 Sep 2020 | 10,000 | 0 (0%) | 0% | 29 | 290,000 | Common Stock |
| Kura Oncology Inc | Marc Grasso | CFO, CBO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Sep 2020 | 7,898 | 105,000 | - | - | Option to purchase common stock | |
| Kura Oncology Inc | Marc Grasso | CFO, CBO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.00 per share. | 14 Sep 2020 | 7,898 | 7,898 (0%) | 0% | 29 | 229,042 | Common Stock |
| Kura Oncology Inc | Marc Grasso | CFO, CBO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Sep 2020 | 2,102 | 247,898 | - | - | Option to purchase common stock | |
| Kura Oncology Inc | Marc Grasso | CFO, CBO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.00 per share. | 14 Sep 2020 | 2,102 | 10,000 (0%) | 0% | 29 | 60,958 | Common Stock |
| Kura Oncology Inc | Marc Grasso | CFO, CBO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Sep 2020 | 10,000 | 112,898 | - | - | Option to purchase common stock | |
| Kura Oncology Inc | Marc Grasso | CFO, CBO | Sale of securities on an exchange or to another person at price $ 26.00 per share. | 08 Sep 2020 | 10,000 | 0 (0%) | 0% | 26 | 260,000 | Common Stock |
| Kura Oncology Inc | Marc Grasso | CFO, CBO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.47 per share. | 08 Sep 2020 | 10,000 | 10,000 (0%) | 0% | 15.5 | 154,700 | Common Stock |
| Kura Oncology Inc | Marc Grasso | CFO, CBO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Aug 2020 | 10,000 | 122,898 | - | - | Option to purchase common stock | |
| Kura Oncology Inc | Marc Grasso | CFO, CBO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.47 per share. | 25 Aug 2020 | 10,000 | 10,000 (0%) | 0% | 15.5 | 154,700 | Common Stock |
| Kura Oncology Inc | Marc Grasso | CFO, CBO | Sale of securities on an exchange or to another person at price $ 23.00 per share. | 25 Aug 2020 | 10,000 | 0 (0%) | 0% | 23 | 230,000 | Common Stock |
| Kura Oncology Inc | Marc Grasso | CFO, CBO | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 07 Aug 2020 | 10,000 | 0 (0%) | 0% | 20 | 200,000 | Common Stock |
| Kura Oncology Inc | Marc Grasso | CFO, CBO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Aug 2020 | 7,102 | 132,898 | - | - | Option to purchase common stock | |
| Kura Oncology Inc | Marc Grasso | CFO, CBO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.47 per share. | 07 Aug 2020 | 7,102 | 10,000 (0%) | 0% | 15.5 | 109,868 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges